Literature DB >> 14714159

Management of cholangitis.

Philippus C Bornman1, Johan I van Beljon, Jake E J Krige.   

Abstract

Acute cholangitis remains a life-threatening complication of biliary obstruction, particularly in the elderly with comorbid disease or when there is a delay in diagnosis and treatment. The initial management consists of fluid resuscitation, correction of coagulopathy, and administration of broad-spectrum antibiotics. The choice of antibiotics should cover both gram-negative and gram-positive organisms associated with cholangitis until the results of a blood culture are available. The timing and choice of biliary decompression varies depending on the response to antibiotic therapy, the presence of comorbid disease, and the underlying cause. Biliary sepsis resolves in most patients with conservative treatment, thus allowing time to perform more detailed non-interventional imaging (e.g., spiral computed tomography [CT], magnetic resonance cholangiopancreatography [MRCP]) to determine the underlying cause and level of biliary obstruction. Those with cholangitis who do not respond to conservative therapy will require urgent biliary decompression. In patients with choledocholithiasis, endoscopic drainage is now the treatment of choice or, if this fails, transhepatic biliary decompression is a useful alternative. Various endoscopic options are available for managing choledocholithiasis, ranging from endoscopic papillotomy (EP) and extraction of stones, to the placement of a biliary drainage system. In patients who respond to antibiotic therapy, EP with stone extraction is preferred, while in those with ongoing sepsis and multiple large stones, the placement of a stent with or without an EP is the safest option. Transhepatic biliary drainage is now reserved for failure of endoscopic drainage and for patients with suspected hilar cholangiocarcinoma or intrahepatic stones. Surgical biliary decompression is seldom required in the emergency setting, but still plays an important role in the definitive treatment of the underlying cause.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14714159     DOI: 10.1007/s00534-002-0710-1

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  12 in total

1.  What are the risk factors for acute suppurative cholangitis caused by common bile duct stones?

Authors:  Dong Han Yeom; Hyo Jeong Oh; Young Woo Son; Tae Hyeon Kim
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

2.  Operable malignant jaundice: To stent or not to stent before the operation?

Authors:  Rungsun Rerknimitr; Pinit Kullavanijaya
Journal:  World J Gastrointest Endosc       Date:  2010-01-16

3.  Principles of source control in the early management of sepsis.

Authors:  John C Marshall
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725

4.  The use of antibiotics for acute pancreatitis: is there a role?

Authors:  Hans G Beger; Frank Gansauge; Bertram Poch; Michael Schwarz
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

5.  Acute bacterial cholangitis.

Authors:  Mamta K Jain; Rajeev Jain
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

6.  Resistant pathogens in biliary obstruction: importance of cultures to guide antibiotic therapy.

Authors:  Michael J Englesbe; Lillian G Dawes
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

7.  Risk factors of organ failure in patients with bacteremic cholangitis.

Authors:  Ban Seok Lee; Jin-Hyeok Hwang; Sang Hyub Lee; Sang Eon Jang; Eun Sun Jang; Hyun Jin Jo; Cheol Min Shin; Young Soo Park; Jin-Wook Kim; Sook-Hyang Jung; Nayoung Kim; Dong Ho Lee; Jun Kyu Lee; Soyeon Ahn
Journal:  Dig Dis Sci       Date:  2012-11-22       Impact factor: 3.199

8.  Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes.

Authors:  M Melzer; R Toner; S Lacey; E Bettany; G Rait
Journal:  Postgrad Med J       Date:  2007-12       Impact factor: 2.401

9.  Clinical epidemiology and outcomes of biliary tract infections caused by Klebsiella pneumoniae.

Authors:  Lanyu Li; Changqing Zhu; Huan Huang
Journal:  Ann Transl Med       Date:  2019-07

10.  Extended Spectrum-β-Lactamase or Carbapenemase Producing Bacteria Isolated from Patients with Acute Cholangitis.

Authors:  Ja Chung Goo; Mun Hyuk Seong; Young Kwang Shim; Hee Seung Lee; Joung-Ho Han; Jung-Ho Han; Kyeong Seob Shin; Jae-Woon Choi; Sei Jin Youn; Seon Mee Park
Journal:  Clin Endosc       Date:  2012-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.